Cancer (Oncology) Trials

Return to Cancer Search

ZUMA-4: A Phase 1-2 Multi-Center Study Evaluating the Safety and Efficacy of KTE-C19 in Pediatric and Adolescent Subjects with Philadelphia Chromosome-Negative Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (r/r ALL)

IRB/UVa Tracking #: 19087

Principal Investigator: Daniel Lee

Contact: Cynthia Fischer

Tel: +1 434-243-0910

Email: crb3y@virginia.edu